Gummy Supplements: Product Development, Formulation & Manufacturing

Gummies can be attractive when the intended product benefits from a chewable, flavour-led experience and its ingredient system can be delivered within a sensible serving architecture.

They may be particularly worth evaluating when:

• consumer experience is important to the product proposition;
• swallowing capsules or tablets is undesirable;
• the required dose can potentially be distributed across an acceptable number of gummies;
• flavour can improve the overall product experience;
• the intended actives can be made compatible with the formulation and manufacturing environment;
• the resulting pack architecture and economics remain practical.

But format popularity is not enough reason to select gummies.

A product requiring a large quantity of functional material, for example, may need a larger gummy, several gummies per serving, or substantial compromises elsewhere in the formulation.

The right development process therefore starts with the product requirement, not the desired format.

Suppose two founders both want to develop a gummy.

One requires 30 mg/day of a botanical extract.

The other requires 5,000 mg/day of a functional ingredient.

Calling both products “gummies” disguises the fundamental formulation difference between them.

Before discussing flavour, shape or bottle design, the developer needs to understand:

target daily dose → actual raw-material requirement → gummies per serving → material per gummy → finished gummy mass → remaining formulation space

Even this calculation only describes mass balance.

It does not tell us whether the formulation will taste acceptable, form correctly, deposit reliably, remain stable or scale commercially.

CO-MANUFACTURING PRINCIPLE:

Format should follow the product requirement—not the other way around.

If preserving the gummy format creates an impractical serving size, poor sensory experience, difficult manufacturing process or unattractive economics, another delivery format may produce the better product.

A useful way to think about gummy capacity is as a formulation-space budget.

A finished gummy has to accommodate more than the headline active ingredient.

Its total mass may need to contain:

FUNCTIONAL INGREDIENTS Deliver the intended nutritional or functional specification.

STRUCTURAL SYSTEM Creates the gel and desired chew.

SWEETENING / BULKING SYSTEM Provides sweetness, solids and part of the physical architecture.

WATER / MOISTURE SYSTEM Influences processing, texture and stability.

ACID / pH SYSTEM Influences taste, formulation environment and potentially gel behaviour.

FLAVOUR / AROMA SYSTEM Creates the intended sensory experience and helps manage off-notes.

COLOUR Supports appearance and product identity where required.

OTHER FUNCTIONAL EXCIPIENTS May support processing, stability or other product requirements.

As the amount of functional material increases, the rest of this system does not disappear.

Instead, one or more things may have to change:

• the gummy becomes larger;
• the serving contains more gummies;
• the matrix changes;
• sensory performance becomes harder to maintain;
• manufacturing becomes harder;
• stability becomes harder;
• another format becomes more attractive.

This is why there is no scientifically defensible universal answer to:

“How many milligrams can a gummy hold?”

Different materials behave differently even at the same mass.

Continue with How much active can a gummy hold? when that decision becomes the active constraint.

Lower material mass generally leaves more room for the gummy matrix, but mass is only one variable.

A small quantity of an active may still create problems through:

• bitterness;
• metallic or mineral taste;
• astringency;
• strong colour;
• aroma;
• poor dispersion;
• oxidation;
• heat sensitivity;
• hygroscopicity;
• interaction with the gelling system.

Published experimental gummy research provides examples where functional ingredients materially changed texture and sensory properties rather than acting as inert added mass.

The useful conclusion is not that a particular ingredient will always behave that way.

It is:

Low mass burden means more formulation space. It does not necessarily mean low formulation complexity.

A supplement gummy is not simply a confectionery base with active ingredients added at the end.

At minimum, development has to coordinate several interacting systems.

ACTIVE SYSTEM Ingredient form, dose, material properties and compatibility.

STRUCTURAL SYSTEM Hydrocolloid architecture responsible for gel formation and texture.

SOLIDS AND SWEETENING SYSTEM Contributes bulk, sweetness and physical behaviour.

ACID / pH SYSTEM Contributes sensory characteristics and changes the formulation environment.

SENSORY SYSTEM Flavour, aroma, sweetness, acidity, colour and masking.

STABILITY SYSTEM The formulation, process and packaging strategy required to maintain the intended product.

These systems can interact directly.

Changing an active, acid, sweetening system or hydrocolloid may therefore require changes elsewhere in the formulation.

Continue with how gummy supplement formulation works when that decision becomes the active constraint.

The usual simplified comparison is:

Pectin = plant-derived

Gelatin = animal-derived

That distinction matters for dietary positioning, but it is inadequate for product development.

The gelling system can also influence:

• gel formation;
• texture;
• elasticity;
• fracture behaviour;
• processing;
• setting;
• interactions with other ingredients;
• stability.

The development question should therefore not be:

“Which one is better?”

It should be:

“Which structural system fits this product’s formulation, desired sensory experience, manufacturing process, dietary positioning and stability requirements?”

For the full matrix decision, continue with Pectin vs Gelatin Gummies.

An ingredient might physically fit while producing a gummy consumers do not want to eat.

Functional ingredients can introduce:

• bitterness;
• metallic notes;
• mineral character;
• chalkiness;
• botanical notes;
• sourness;
• aroma;
• persistent aftertaste.

This creates an important distinction:

Maximum physically incorporable load and maximum sensorially acceptable load are not necessarily the same thing.

Taste masking can itself require formulation space through flavours, sweetness, acidity, ingredient-source changes or other formulation strategies.

Because the active system can alter the product, sensory development should evaluate the actual active-containing formulation rather than assuming that a flavour optimized in a blank base will behave identically once actives are introduced.

EVIDENCE STATUS: The interaction between functional ingredients and sensory/physical properties is supported by published formulation research. The recommendation to develop sensory performance against the actual active system is a CoManufacturing product-development principle.

The desired gummy might be:

• soft;
• firm;
• elastic;
• short-bite;
• chewy;
• coated;
• uncoated.

But texture cannot always be selected independently of the functional ingredients.

Changes to acids, hydrocolloids, nutrients and other formulation components can alter gel-network and textural behaviour.

This means the active system may force adjustments to the gummy base.

A useful prototype therefore needs to be evaluated for more than flavour.

Structured feedback may consider:

appearance → aroma → initial taste → sweetness/acidity → active off-note → aftertaste → firmness → elasticity → chew → stickiness → grittiness → coating → unit consistency

This is substantially more actionable than simply telling an R&D team:

“Make it taste better.”

One common product-development mistake is treating a successful prototype as proof that the product is commercially solved.

CoManufacturing separates feasibility into layers.

THEORETICAL INCORPORATION Can the required material potentially be incorporated into this type of system?

BENCH FEASIBILITY Can a coherent prototype be produced?

SENSORY FEASIBILITY Is the product acceptable to consume?

MANUFACTURING FEASIBILITY Can it be produced consistently using the intended commercial process?

STABILITY VALIDATION Does the finished product maintain the required characteristics through its intended shelf life?

COMMERCIAL FEASIBILITY Do serving count, pack architecture, manufacturing quantity, COGS and consumer experience make sense?

A published laboratory formulation can establish useful technical evidence without proving conventional commercial manufacturing feasibility.

That distinction becomes particularly important when evaluating unusual high-load gummies, pharmaceutical-style gummies or novel manufacturing technologies.

The exact process depends on formulation and equipment, but a commercial architecture can involve stages such as:

raw-material preparation → base preparation/cooking → controlled active and sensory addition → depositing → setting → demoulding → conditioning/drying where applicable → finishing/coating → inspection/testing → packaging

The important questions are what happens to the specific formulation during the process.

For example:

• What temperature does an active experience?
• How long is the mass held before depositing?
• Will suspended material remain sufficiently uniform?
• Does viscosity remain compatible with depositing?
• Does the product set consistently?
• How does conditioning change the product?
• What happens to potency through processing?
• Can the intended pack be run efficiently?

Those are manufacturing questions, not merely ingredient questions. The commercial gummy manufacturing process explains how those controls connect from raw-material qualification through packaging.

For gummies, stability can involve several dimensions at once.

CHEMICAL Does the intended active remain within specification?

PHYSICAL Does the gummy maintain the required structure?

SENSORY Do taste, aroma or colour change?

MOISTURE-RELATED Does the product become harder, softer or sticky?

MICROBIOLOGICAL Does the formulation remain microbiologically acceptable?

PACKAGING-RELATED Does the proposed package provide sufficient protection under the intended storage and distribution conditions?

A good initial prototype does not establish shelf-life performance. Gummy Stability and Water Activity explains how formulation, moisture behaviour, packaging and testing combine into a shelf-life strategy.

CoManufacturing should therefore treat shelf life as something that needs evidence, not simply as a number selected during the product brief.

Potential architectures include:

• bottle or jar;
• stand-up pouch;
• individual wrapping with secondary packaging.

The right choice depends on more than appearance.

Packaging decisions can affect:

• moisture exposure;
• oxygen/light exposure where relevant;
• handling;
• environmental exposure after opening;
• consumer convenience;
• filling/packing compatibility;
• pack dimensions;
• logistics;
• cost.

CO-MANUFACTURING EXPERIENCE:

Individually wrapping gummies can be worth evaluating where environmental exposure and handling create meaningful concerns, including challenging hot/humid distribution environments.

This is not a universal requirement.

Individual wrapping is one possible risk-management architecture, not a default specification for every gummy product.

Important principle:

Packaging can reduce environmental exposure. It cannot repair a fundamentally unstable formulation.

Suppose, purely as an arithmetic example, that a manufacturing run contains 100,000 gummies.

At:

30 gummies/pack = approximately 3,333 theoretical packs

60 gummies/pack = approximately 1,667 theoretical packs

90 gummies/pack = approximately 1,111 theoretical packs

before accounting for yield, QC samples, wastage or other production realities.

Now add serving architecture.

If the product requires four gummies/day, a 60-count pack provides only 15 days of use.

The commercial question is therefore not merely:

“What is the gummy MOQ?”

It is:

“How does the manufacturing quantity translate into servings, finished packs, inventory, packaging requirements and cost per day of use?”

EVIDENCE STATUS: The numbers above are illustrative arithmetic, not manufacturing specifications or industry MOQ benchmarks.

Choosing a different format is not a failed gummy project.

It can be the correct product-development conclusion.

Alternative formats deserve consideration when achieving the target specification would require:

• an excessive number of gummies;
• an inconvenient finished product mass;
• unacceptable taste or texture;
• unsuitable process exposure;
• difficult stability;
• disproportionately expensive packaging;
• poor batch economics.

Depending on the product, alternatives may include capsules, tablets, powders, liquids, oral films or other delivery systems.

The purpose of product development is not to preserve the founder’s first format assumption.

It is to build the best feasible product around the intended consumer and product requirement.

Before requesting prototypes or commercial quotations, a useful development brief should ideally establish:

• target market;
• target consumer;
• intended product function;
• active ingredients;
• target dose of each active;
• exact raw-material forms where known;
• desired gummies per daily serving;
• dietary requirements;
• pectin/gelatin preference if already constrained;
• sugar/sugar-free requirement;
• flavour direction;
• colour requirements;
• intended pack count;
• packaging preference;
• target shelf life;
• distribution/storage environment;
• target retail price or commercial constraints;
• expected launch quantity.

Not every answer has to be known at the beginning.

Unknowns are exactly what product development is supposed to resolve.

But identifying them explicitly is better than allowing them to become hidden assumptions.

A good gummy is not the formulation containing the greatest possible quantity of active material.

It is the formulation that delivers the intended product requirement while preserving:

dose

• consumer experience
• manufacturability
• stability
• commercial viability.

That is the standard against which the format should be evaluated.

Evidence guide: Published evidence — supported by linked literature. · CoManufacturing experience — practical development reasoning, not a universal specification. · Manufacturer-specific — confirm against the selected process and supplier. · Project-specific / requires validation — prove with the actual formula, process, pack and market.

• Hu et al., “Perspective on Gummy Dietary Supplements Manufacturing and Testing,” Journal of Dietary Supplements (2026). PubMed · doi:10.1080/19390211.2026.2727022
• Adeleke and Abedin, “Characterization of Prototype Gummy Formulations Provides Insight into Setting Quality Standards,” AAPS PharmSciTech (2024). PubMed · doi:10.1208/s12249-024-02876-w
• FDA, “Water Activity (aw) in Foods.” Official technical guide
• Rivero et al., “Natural Ingredients-Based Gummy Bear Composition Designed According to Texture Analysis and Sensory Evaluation In Vivo,” Molecules (2019). PubMed

These sources support the need to evaluate formulation, quality, texture, sensory performance and moisture-related stability. They do not establish a universal gummy weight, payload limit, shelf life or commercial process specification.